Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferric ion (Fe3+) and other polyvalent metal ions, such as aluminum (Al3+) and copper (Cu2+), are essential inorganic elements that serve as critical cofactors for enzymes and structural components of proteins (NIH, 2023). While necessary for life, an excess of these ions can lead to significant pathology; for example, free ferric iron catalyzes the formation of hydroxyl radicals via the Fenton reaction, causing oxidative damage to DNA and membranes (StatPearls, 2023). In clinical pharmacology, these ions are targeted by chelating agents—such as deferoxamine, deferasirox, and penicillamine—which bind the metal ions to form stable, water-soluble complexes that can be safely excreted (PubChem, 2024). Additionally, polyvalent ions like magnesium and aluminum are targeted in the gastrointestinal tract by antacids and phosphate binders to manage gastric acidity and hyperphosphatemia, respectively (StatPearls, 2022). Therapeutic management of these ions is vital in treating disorders like hemochromatosis, Wilson's disease, and chronic kidney disease (Mayo Clinic, 2023). However, clinicians must balance the removal of toxic excesses with the risk of depleting essential minerals, which can lead to secondary deficiencies and systemic toxicity (PubMed, 2021).
Chelation of metal ions to form stable, excretable complexes; neutralization of gastric acid; binding of dietary phosphate in the gastrointestinal tract.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferric ion and other polyvalent metal ions (Fe3+).